|
HS Code |
609978 |
| Product Name | 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One |
| Cas Number | 2385-85-5 |
| Molecular Formula | C12H11NO3 |
| Molecular Weight | 217.22 g/mol |
| Appearance | Yellow to orange crystalline powder |
| Melting Point | 113-115°C |
| Solubility | Soluble in most organic solvents |
| Storage Conditions | Store in a cool, dry place, protect from light |
| Purity | Typically ≥98% |
| Synonyms | EMPO, Ethoxymethylenoxazolone |
| Hazard Statements | Irritant |
As an accredited 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25g amber glass bottle, sealed with a screw cap, and labeled with hazard and product information. |
| Shipping | 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One is shipped in tightly sealed containers, protected from moisture and light. It is labeled according to hazardous material regulations and handled by trained personnel. Transportation is typically via ground or air with all documentation, ensuring compliance with local and international chemical shipping standards for safety and security. |
| Storage | **4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One** should be stored in a tightly sealed container, away from moisture and direct sunlight, in a cool, dry, and well-ventilated area. Keep it separate from incompatible substances such as strong oxidizers and acids. Use appropriate safety measures, including gloves and eye protection, when handling to avoid contact with skin and eyes. |
Applications of 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One in Industrial ManufacturingAs an advanced oxazolone derivative, 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One supports high-value specialty synthesis in well-regulated sectors. As the original manufacturer, we provide this raw material primarily to leading downstream customers in active pharmaceutical ingredient production, specialty peptide synthesis, diagnostic reagents, and research-grade fine chemicals. The following scenarios detail direct marketplace usage, focused on industry-specific standards, functional dosage, integration steps, and the resulting finished goods. 1. Peptide Synthesis IntermediatesPeptide manufacturers engaged in protected solid-phase peptide synthesis and solution-phase fragment condensation processes depend on this reagent as an efficient peptide-coupling intermediate. Its use as an activated amino acid ester enables efficient, racemization-minimized coupling, especially in the synthesis of N-terminal protected dipeptides, oligopeptides, and modified peptides under cGMP conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Intermediate ManufacturingThe compound is widely selected in small-molecule synthetic programs as a highly efficient reagent for the activation of carboxylic acids, particularly for the construction of amide linkages and heterocyclic scaffolds. Process chemists at regulated API sites apply it to streamline amide bond formation with sensitive amines, minimizing racemization and improving batch consistency during route development and scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Diagnostic Peptide Conjugate ManufacturingDiagnostic reagent formulators use the oxazolone ring in the preparation of peptide conjugates for immunoassay controls, fluorescent probes, and biotinylated tracers. Site-specific conjugation relies on its high selectivity under mild conditions, supporting conjugate purity and batch reproducibility for global IVD platforms and specialty diagnostic kit producers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis for Research ReagentsChemical suppliers producing high-purity building blocks and specialty reagents deploy this intermediate to construct oxazolone-containing molecules—frequently utilized as reference standards, analytical markers, and probe molecules in chemical biology. Consistent availability and controlled impurity profiles underpin robust performance in academic, contract research, and biotechnology laboratory sectors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One brings a specific value to synthetic chemistry, especially in peptide coupling and β-lactam antibiotic intermediates. In our plant, every batch we create follows a process supported by years of refinement. Our daily work with this material reveals more than what typical data sheets show—the practical differences during synthesis, its actual performance in coupling steps, and what users genuinely experience in the lab or industrial setting. Putting this experience into words helps demystify the sometimes overlooked factors that set one producer’s material apart from another’s.
4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One often features where synthetic efficiency matters most, especially in research and production environments looking to improve yields or obtain particular diastereomers. Whether the demand comes from a pharmaceutical developer trying to shorten process steps or a specialty chemical firm optimizing its own workflow, this molecule plays a consistent role.
Whenever colleagues in peptide synthesis reach out, their requests rarely hover around purity figures alone. What comes up regularly is “how does your material behave in actual condensation reactions?” From our side, we monitor moisture content, residual solvents, and trace impurities—not just at final QC, but through each stage of every batch. Some clients report problems with competitive products: yellowing on storage, unexpectedly high hydrolysis during shipping, or stubborn clumps slowing dissolution. Through process adjustments, attention to particle size, and selection of approvals, we have minimized those headaches. Our own lots, for example, stand up to long transport times and keep their snow-white appearance, even when exposed briefly to humid air—an outcome owed to a specific drying and packing protocol we refined after feedback from people running pilot plants in Southeast Asia.
Some ask, “does your 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One meet ACS or pharma-grade requirements?” Rather than quoting standards, we focus on the hands-on impact—process yields, batch-to-batch reproducibility, and shelf life. As example, our average batch purity hits 99.3% by HPLC, with single-side impurity profiles checked by NMR before release. Most buyers notice that quality stability first, especially groups used to seeing more batch fluctuation from non-manufacturer channels. We invest effort to avoid dry-down artifacts, such as excess ethoxy and yellowish tints, since even minor discoloration can trigger doubts among QA auditors. On the instrument side, melting point (typically 145–148°C for our standard grade) and water content (less than 0.1% by Karl Fischer) directly reflect our control during the last distillation and vacuum drying stages.
Handling speaks volumes. Our team, working in shifts, spends as much time re-checking the packing process as the initial synthesis itself. By using high-barrier, double poly-liner drums and storing stock in low-humidity, temperature-controlled areas, we maintain performance above specifications, not just at delivery but months after. This attention has tangible benefits: one customer mentioned their own lab had switched to our supply after fighting clumping and re-crystallization issues with a different source. The improvement in their hands saved days spent on sample pre-treatment alone.
Perhaps the most in-demand usage for this molecule comes from peptide coupling. The compound is prized for its contribution to forming peptide bonds selectively under mild conditions and its ability to minimize racemization. Our own process experts note that customers using non-manufacturer sources often see byproduct formation they can’t trace. After switching to our grade, side reactions usually decline. Side-by-side tests using standard Fmoc or Boc synthesis protocols show a drop in byproduct peaks on HPLC with our material. That’s not only a numbers game—it leads to cleaner products and, most important, fewer surprises scaling up from bench to pilot. These realities stack up to saved time, cost, and regulatory rework.
Another major field is β-lactam antibiotic intermediate production. There, slight differences in moisture or impurity content can set off chain reactions in downstream steps, affecting final active pharmaceutical ingredient quality. Labs working on generic penicillin derivatives have told us that the clarity and stability of their solutions improved noticeably after moving to our consistent supply. This feedback shapes our priorities—each optimization in drying and filtration translates into fewer customer complaints and greater loyalty.
Producing 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One isn’t just about chemistry; it’s about predictability in a globalized market. Input quality, skilled oversight, and transparent records have a domino effect on what users achieve with their processes. From the start, our facility made a decision not to subcontract any step of the main synthetic pathway. That means we control sourcing of key raw materials—like benzoyl chloride and glycine derivatives—down to approved suppliers, pre-tested before shipment. We regularly invest in plant maintenance, focusing on reactor cleanliness, and we track process data during each run. Each adjustment, often inspired by end user feedback, pushes our output towards the level clients expect from a qualified manufacturer, not a repackager.
Only those inside a manufacturer’s operation see the subtle but meaningful differences in final product. Reseller-bought lots tend to show larger variation in color, mix-in times, or clumping after storage. Some report issues with premature polymerization or formation of hydrolysis byproducts. Those outcomes rarely stem from synthesis alone; they stem from decisions made post-synthesis: vacuum level controls, filter media quality, and type of desiccant used during shipment. By holding each drum for final inspection, we reduce the chance of polymorph contamination or cross-contact with incompatible chemicals—a surprisingly common problem outside vertically integrated facilities.
Even the seemingly mundane details count. Particle size uniformity, for instance, affects slurry preparation and mixing efficiency in continuous processes. After receiving feedback, we implemented gentle milling and air classification steps, which reduced sedimentation in our standard grade and made for faster dissolving in both small and large-scale applications.
No single set of specifications covers all market demand. Over time, we realized that some partners require extra low water content, targeting electrophilic couplings, while others prioritize cost per kilogram above all. For this reason, we produce two main variants:
Every adjustment to our process flows from direct industry feedback. Over the years, we’ve learned that lab-scale researchers and plant engineers view product “quality” quite differently. A research chemist in Europe might look for the sharpest melting point and minimal baseline drift in analytical test results. By contrast, a plant manager in India might demand certainty in supply chain, minimal drum-to-drum variation, and prompt document support when auditors ask tough questions. Acting only as a supplier instead of a true manufacturer loses sight of those differences. We keep adapting; following a period where more customers from humid climates reported caking, we overhauled packing lines and introduced molecular sieve inserts in every outbound drum. Complaints dropped, and reshipping requests nearly disappeared.
As global regulatory scrutiny around chemical precursors grows, users want more than a standard certificate of analysis. That’s clear from the number of requests for supporting method data, IQ/OQ documentation, or details about traceability for every lot. Many manufacturers try to patch gaps with generic data or “meets specification” claims. We respond by providing direct links—actual run data, validation records from our own QC labs, and measured impurity spectra. On some projects, our team has provided side-by-side impurity lists for six consecutive batches, exposing trends over time. This extra layer of openness gives end users ammunition for their own regulatory filings and builds the trust missing from traders or secondary suppliers. It’s not just about compliance, but delivering a sense that their materials really do come from an accountable, reliable source.
Our role as manufacturer doesn’t end at shipment. Many customer labs ask for guidance on storage, especially in locations where room temperature fluctuates or long-term inventory is unavoidable. Over the last decade, we tested various container types, inner liners, and desiccants to find an approach that preserved color, texture, and dissolution properties for the longest periods. We now recommend, and ship by default, only with sealed poly-drums holding less than 1% headspace, each nested with a moisture indicator. These details mean users receive a compound as close as possible to what was produced fresh, not an aged lot with degraded or altered performance.
We also know that shelf life isn’t just an afterthought. Some competitors quietly re-bag material that’s months or years old, risking subpar results for complex applications. Our batches display clear production and release dates. We have set internal rules to prohibit any repackaging outside our own plant. By prioritizing such controls, we protect end users from the risk of compromised product and unplanned downtime.
Increasingly, concerns about sustainability and environmental safety influence procurement decisions. From our perspective, true stewardship begins on the factory floor. Our site recycles process solvents, and we have set targets for reducing total organic emissions over the next five years. By working closely with partner waste handlers, we ensure that expired or substandard lots are validated, documented, and broken down safely—not resold into secondary channels. Some customers have toured our facility as part of their due diligence, comparing our processes with their internal criteria for ethical sourcing. This open-door approach benefits everyone: better alignment with end users and improved confidence for all parties involved in the supply chain.
Markets for 4-Ethoxymethylene-2-Phenyl-2-Oxazolin-5-One continue to grow, especially with the uptick in demand for synthetic peptides and new antibiotics. Requirements for quality, process transparency, and supply continuity get stricter each year. Through ongoing investment in new analytical methods, tighter raw material controls, and real feedback loops with industrial users, manufacturers like us can adapt to both future regulatory expectations and operational needs.
Every change in process or packaging comes from our real-world experience and honest dialogue with users. In an industry shaped by reliability and predictability, these commitments—not just technical data—help differentiate those who truly understand the product from those who only pass it along.